NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 24 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,580 | -71.0% | 125,866 | +213.1% | 0.00% | – |
| Q4 2021 | $40,000 | -91.3% | 40,200 | -84.7% | 0.00% | – |
| Q3 2021 | $459,000 | -15.8% | 262,245 | -11.8% | 0.00% | – |
| Q2 2021 | $545,000 | +39.4% | 297,432 | +53.9% | 0.00% | – |
| Q1 2021 | $391,000 | -39.5% | 193,217 | -35.6% | 0.00% | – |
| Q4 2020 | $646,000 | +44.2% | 299,976 | +80.6% | 0.00% | – |
| Q3 2020 | $448,000 | +28.4% | 166,100 | +87.6% | 0.00% | – |
| Q2 2020 | $349,000 | +2226.7% | 88,521 | +347.1% | 0.00% | – |
| Q1 2020 | $15,000 | -79.7% | 19,800 | -66.4% | 0.00% | – |
| Q4 2019 | $74,000 | +208.3% | 59,000 | +74.6% | 0.00% | – |
| Q3 2019 | $24,000 | +200.0% | 33,800 | +166.1% | 0.00% | – |
| Q2 2019 | $8,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 52,926 | $113,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,940 | $236,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $22,000 | 0.00% |
| Sowell Financial Services LLC | 11,190 | $24,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 101,949 | $219,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 32,822 | $71,000 | 0.00% |
| UBS Group AG | 816 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $2,000 | 0.00% |